Share on StockTwits

Chemed (NYSE:CHE) shares reached a new 52-week high during mid-day trading on Thursday , ARN reports. The stock traded as high as $96.41 and last traded at $96.30, with a volume of 224,780 shares. The stock had previously closed at $95.10.

Several analysts have recently commented on the stock. Analysts at RBC Capital raised their price target on shares of Chemed from $70.00 to $74.00 in a research note on Tuesday, June 10th. They now have a “sector perform” rating on the stock. Separately, analysts at Deutsche Bank reiterated a “hold” rating on shares of Chemed in a research note on Thursday, May 1st. They now have a $75.00 price target on the stock. Finally, analysts at Oppenheimer raised their price target on shares of Chemed from $90.00 to $92.00 in a research note on Thursday, May 1st. They now have an “outperform” rating on the stock. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $83.73.

The stock’s 50-day moving average is $91.01 and its 200-day moving average is $85.28. The company has a market cap of $1.691 billion and a price-to-earnings ratio of 23.17.

Chemed (NYSE:CHE) last released its earnings data on Tuesday, April 29th. The company reported $1.32 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.32. The company had revenue of $358.30 million for the quarter, compared to the consensus estimate of $256.77 million. During the same quarter in the previous year, the company posted $1.38 earnings per share. The company’s revenue for the quarter was down 2.3% on a year-over-year basis. On average, analysts predict that Chemed will post $5.88 earnings per share for the current fiscal year.

Chemed Corporation (NYSE:CHE) purchases, operates and divests subsidiaries engaged in diverse business activities.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.